Related Experiment Videos
The central melanocortin system can directly regulate serum insulin levels
W Fan1, D M Dinulescu, A A Butler
1The Vollum Institute, Oregon Health Sciences University, Portland 97201, USA.
Endocrinology
|August 31, 2000
Summary
The central melanocortin system regulates energy balance and glucose metabolism. Disruptions in this system impact insulin release and glucose tolerance, potentially contributing to obesity-associated type II diabetes.
Area of Science:
- Neuroendocrinology
- Metabolic Regulation
- Obesity Research
Background:
- The central melanocortin system is crucial for maintaining energy homeostasis.
- Genetic defects in this system lead to obesity in humans and mice.
- Melanocortin agonists centrally administered inhibit food intake and increase oxygen consumption.
Purpose of the Study:
- To investigate the role of the central melanocortin system in regulating insulin release and glucose tolerance.
- To explore the impact of melanocortin system dysfunction on energy partitioning and insulin responsiveness.
Main Methods:
- Administration of melanocortin agonists centrally.
- Analysis of plasma insulin levels in MC4-R knockout (MC4-RKO) mice.
- Assessment of glucose tolerance and insulin tolerance in MC4-RKO mice.
Main Results:
- Centrally administered melanocortin agonists inhibit basal insulin release and alter glucose tolerance.
- Young, lean MC4-RKO mice exhibit increased plasma insulin levels and impaired insulin tolerance prior to obesity.
- These findings indicate the melanocortin system's role in energy partitioning.
Conclusions:
- The central melanocortin system regulates energy intake, expenditure, and energy partitioning.
- Defects in central glucose homeostasis control may contribute to obesity-associated type II diabetes.
- The melanocortin system's influence on insulin dynamics offers new insights into metabolic disorders.